Novum Peptides

Research use only

Before you enter

Please confirm the following before browsing Novum Peptides.

Adults onlyYou must be 18 years or older to enter.

Laboratory research onlyOur products are not for human or veterinary use.

We’ll remember your confirmation on this browser where storage is available.

Novum Peptides · For laboratory research only

Orthogonal assays for a proposed peptide mechanism

Assess whether several experiments provide independent support for a peptide mechanism or repeat the same unresolved assumption.

A mechanism can look convincing when a paper contains many positive graphs. The important question is whether those graphs test different parts of the explanation. Orthogonal assays use a different measurement approach to investigate a relevant claim, helping distinguish an underlying effect from the limitations of one detection system.

Give each follow-up assay a specific job

The Assay Guidance Manual distinguishes orthogonal assays from counterscreens that investigate interference with the detection system. It also cautions that a positive orthogonal result does not by itself establish the desired mechanism of action; further target-specific evidence may be needed.Assay Guidance Manual — Interferences with Luciferase Reporter Enzymes (opens in a new tab)

Before reading the results, write the proposed claim as a short chain: the peptide reaches the relevant setting, engages the proposed target and changes the measured process through that interaction.

Each experiment should support a particular link. A test that confirms a downstream response is useful, but it does not automatically fill a missing link about direct binding.

Repeating an experiment addresses reproducibility of that measurement. Changing the measurement approach addresses a different question about whether its assumptions are driving the result. A strong study may need both.

Distinguish shared signals from independent evidence

Original hypothetical evidence map
ExperimentSupportsDoes not alone prove
Optical enzyme assayChange in the assay signalDirect target binding
Product-specific assayChange in measured productSelectivity across other targets
Binding measurementInteraction under tested conditionsCause of a cellular phenotype
Target-dependence comparisonRole of the target in that modelEvery step of the proposed pathway

The table is an illustrative reading framework, not a fixed checklist that every paper must execute. The appropriate evidence depends on the claim and the model.

If two assays use the same reporter enzyme, a compound acting on that reporter can remain a shared alternative explanation. Different kit names do not necessarily mean different vulnerabilities.

If one assay measures binding in buffer and another measures a cell response, their agreement is encouraging but the intervening exposure and target-dependence questions still matter.

For a review note, identify the shared assumption in plain language. This is more informative than simply labelling a group of methods independent because they appear in separate figures.

Keep target engagement separate from downstream outcome

Martinez Molina and colleagues introduced the cellular thermal shift assay as a way to evaluate drug binding to target proteins in cells and tissues through ligand-associated thermal stabilisation. This illustrates a measurement directed towards target engagement rather than merely a downstream phenotype.Martinez Molina and colleagues — Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay (opens in a new tab)

The original method is not a promise that every peptide–target pair produces a useful thermal signal. A paper using it must establish that its particular comparison is interpretable.

More generally, a target-engagement result and a functional result should retain their own conditions and limits. Binding somewhere in the system does not automatically establish that the observed phenotype arose through that interaction.

Use disagreement to locate the missing explanation

If an optical assay changes but a product-specific measurement does not, first compare their targets, timing and sensitivity. Do not select the more favourable result without explaining the discrepancy.

If binding is detected without a cell response, the finding may still establish an interaction under the binding conditions. It does not establish either cellular efficacy or complete biological inactivity.

A sound summary states which links in the mechanism are supported and which remain uncertain. It can also distinguish a hypothesis weakened by a contradictory result from one that was never adequately tested.

This approach makes the research record easier to extend. A later paper can address a specific missing connection instead of merely adding another assay to an already long list of positive observations.

Sources and further detail

  1. Assay Guidance Manual — Interferences with Luciferase Reporter Enzymes (opens in a new tab)

    Section on primary, secondary, orthogonal and counterscreen roles read in the official chapter/PDF. Brief distinctions only; no assay protocol or blanket dismissal of secondary assays.

  2. Martinez Molina and colleagues — Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay (opens in a new tab)

    Original 2013 abstract and author metadata read. Used as a limited target-engagement example, not validation for arbitrary peptides. Evidence map and hypothetical disagreements are original.

Sources checked 19 September 2026. Worked examples are illustrative unless a supplied report is explicitly identified. This article has not undergone independent scientific peer review.